Skip to main content
. 2022 May 14;24(6):779–788. doi: 10.1111/jch.14500

TABLE 3.

Multiple logistic regression models of visit‐to‐visit blood pressure variability with adverse neonatal outcomes

Outcomes Quartile 1 Quartile 2 Quartile 3 Quartile 4 p for trend
Fetal distress
SBP SD Model 1 Reference 1.04 (.98–1.11) 1.08 (1.02–1.15) 1.10 (1.04–1.17) .001
Model 2 Reference 1.00 (.94–1.07) 1.03 (.97‐1.10) 1.03 (.97‐1.09) .298
Model 3 Reference 1.00 (.94–1.07) 1.04 (.97‐1.11) 1.05 (.98‐1.12) .115
SBP CV Model 1 Reference 1.04 (.97–1.10) 1.08 (1.02‐1.15) 1.06 (1.00‐1.13) .049
Model 2 Reference 1.03 (.96–1.09) 1.06 (.99‐1.13) 1.05 (.98‐1.11) .141
Model 3 Reference 1.02 (.95–1.08) 1.05 (.98‐1.12) 1.05 (.98‐1.12) .104
DBP SD Model 1 Reference 1.12 (1.06–1.20) 1.22 (1.15–1.30) 1.26 (1.19–1.34) <.001
Model 2 Reference 1.09 (1.02–1.16) 1.15 (1.08–1.23) 1.15 (1.08–1.23) <.001
Model 3 Reference 1.09 (1.02–1.16) 1.17 (1.10–1.25) 1.19 (1.11–1.27) <.001
DBP CV Model 1 Reference 1.04 (.98–1.11) 1.11 (1.05–1.18) 1.20 (1.13‐1.28) <.001
Model 2 Reference 1.04 (.98–1.11) 1.10 (1.03–1.17) 1.16 (1.09–1.23) <.001
Model 3 Reference 1.05 (.98–1.12) 1.13 (1.05–1.20) 1.22 (1.14–1.30) <.001
Small for gestational age
SBP SD Model 1 Reference 1.32 (1.13–1.54) 1.16 (.99–1.36) 1.58 (1.36–1.84) <.001
Model 2 Reference 1.29 (1.10–1.50) 1.11 (.95–1.31) 1.49 (1.28–1.73) <.001
Model 3 Reference 1.25 (1.07–1.46) 1.07 (.91–1.25) 1.35 (1.16–1.58) .001
SBP CV Model 1 Reference 1.14 (.98–1.34) 1.26 (1.08–1.47) 1.34 (1.15–1.56) <.001
Model 2 Reference 1.11 (.95–1.29) 1.17 (1.01–1.37) 1.22 (1.05–1.43) .009
Model 3 Reference 1.12 (.96–1.31) 1.20 (1.02–1.40) 1.26 (1.08–1.47) .004
DBP SD Model 1 Reference 1.05 (.89–1.23) 1.17 (1.00–1.36) 1.49 (1.29–1.73) <.001
Model 2 Reference 1.01 (.86–1.19) 1.11 (.95–1.30) 1.40 (1.21–1.63) <.001
Model 3 Reference 1.00 (.85–1.18) 1.09 (.93–1.28) 1.32 (1.14–1.54) <.001
DBP CV Model 1 Reference 1.06 (.91–1.24) 1.14 (.98–1.33) 1.30 (1.12–1.51) <.001
Model 2 Reference 1.02 (.87–1.19) 1.07 (.92–1.25) 1.19 (1.02–1.38) .014
Model 3 Reference 1.09 (.93–1.27) 1.19 (1.01–1.39) 1.38 (1.17–1.61) <.001
Preterm birth
SBP SD Model 1 Reference .82 (.73–.92) .85 (.76–.96) 1.06 (.95–1.19) .079
Model 2 Reference .82 (.73–.93) .86 (.77–.97) 1.08 (.96–1.20) .045
Model 3 Reference .80 (.71–.90) .82 (.73–.92) .96 (.86–1.08) .994
SBP CV Model 1 Reference .79 (.70–.89) .85 (.76–.95) .94 (.84–1.05) .675
Model 2 Reference .80 (.71–.90) .87 (.77–.97) .97 (.86–1.08) .883
Model 3 Reference .80 (.71–.90) .88 (.78–.99) .97 (.86–1.09) .861
DBP SD Model 1 Reference .81 (.72–.91) .82 (.73–.92) 1.01 (.90–1.13) .418
Model 2 Reference .82 (.73–.92) .83 (.74–.94) 1.04 (.93–1.16) .181
Model 3 Reference .80 (.71–.90) .79 (.70–.89) .95 (.85–1.07) .776
DBP CV Model 1 Reference .80 (.72–.90) .86 (.77–.96) .87 (.78–.97) .085
Model 2 Reference .82 (.73–.92) .89 (.79–.99) .91 (.81–1.02) .352
Model 3 Reference .85 (.76–.96) .91 (.81–1.03) .95 (.84–1.08) .801
1‐min Apgar score≤7
SBP SD Model 1 Reference 1.02 (.83–1.27) .88 (.71–1.10) 1.13 (.91–1.39) .357
Model 2 Reference 1.02 (.82–1.26) .88 (.70–1.09) 1.12 (.91–1.38) .383
Model 3 Reference 1.00 (.81–1.24) .86 (.69–1.07) 1.06 (.85–1.31) .755
SBP CV Model 1 Reference .90 (.73–1.11) .84 (.67–1.04) .98 (.80–1.21) .894
Model 2 Reference .92 (.74–1.13) .86 (.69–1.07) 1.04 (.84–1.28) .698
Model 3 Reference .91 (.73–1.12) .84 (.68–1.05) 1.00 (.81–1.24) .972
DBP SD Model 1 Reference .95 (.76–1.19) 1.10 (.89–1.37) 1.35 (1.09–1.66) <.001
Model 2 Reference .95 (.76–1.19) 1.11 (.89–1.38) 1.35 (1.09–1.66) .001
Model 3 Reference .96 (.76–1.20) 1.10 (.88–1.37) 1.32 (1.06–1.63) .003
DBP CV Model 1 Reference .93 (.74–1.16) 1.04 (.84–1.29) 1.29 (1.05–1.59) .004
Model 2 Reference .97 (.77–1.21) 1.09 (.88–1.36) 1.37 (1.12–1.70) <.001
Model 3 Reference .99 (.79–1.24) 1.12 (.90–1.40) 1.43 (1.14–1.79) <.001
5–min Apgar score≤7
SBP SD Model 1 Reference .90 (.48–1.70) .70 (.35–1.39) .75 (.38–1.47) .335
Model 2 Reference .89 (.47–1.69) .69 (.35–1.36) .73 (.37–1.43) .297
Model 3 Reference .88 (.46–1.66) .66 (.33–1.32) .66 (.33–1.31) .186
SBP CV Model 1 Reference .76 (.40–1.46) .76 (.40–1.46) .67 (.34–1.31) .264
Model 2 Reference .75 (.39–1.44) .74 (.38–1.41) .64 (.32–1.26) .212
Model 3 Reference .73 (.38–1.40) .69 (.36–1.34) .57 (.28–1.14) .120
DBP SD Model 1 Reference .50 (.23–1.07) .90 (.48–1.70) .95 (.51–1.78) .721
Model 2 Reference .49 (.23–1.06) .88 (.46–1.66) .91 (.48–1.71) .821
Model 3 Reference .49 (.23–1.05) .85 (.45–1.62) .84 (.44–1.62) .987
DBP CV Model 1 Reference .71 (.34–1.48) 1.30 (.69–2.44) .94 (.48–1.86) .796
Model 2 Reference .69 (.33–1.45) 1.25 (.66–2.36) .89 (.45–1.77) .929
Model 3 Reference .67 (.32–1.41) 1.18 (.61–2.26) .80 (.39–1.66) .826

Note: Model 1 was unadjusted. Model 2 was adjusted for body mass index, age, gravidity, parity, cesarean, in vitro fertilization‐embryo transfer. Model 3 was adjusted for covariates in Model 2 and hypertensive disorders (normotension, gestational hypertension/preeclampsia), gestational diabetes mellitus, premature rupture of membranes, cephalic presentation, scarred uterus, anemia, mean SBP and mean DBP.

Abbreviations: CV, coefficient of variation; DBP, diastolic blood pressure; SBP, systolic blood pressure; SD, standard deviation.